Europe Organ Preservation Market

Europe Organ Preservation Market Size 

The Europe Organ Preservation Market was valued at USD 57.47 million in 2024. The Europe Organ Preservation Market is expected to have 7% CAGR from 2025 to 2033 and be worth USD 105.66 million by 2033 from USD 61.49 million in 2025.  

In Europe, the rising demand for effective techniques and solutions to extend the viability of organs intended for transplantation is primarily fuelling the demand for organ preservation services in this region. Organ preservation involves the use of specialized methods and technologies to maintain the physiological integrity of harvested organs until they are transplanted into recipients. According to the European Society for Organ Transplantation, over 30,000 organ transplants are performed annually in Europe, underscoring the vital role of preservation techniques in ensuring successful outcomes. The European organ preservation market has been growing steadily over the last few years owing to the advancements in preservation technologies, increasing organ donation rates, and rising awareness about transplantation as a life-saving intervention.

MARKET DRIVERS

Increasing Demand for Organ Transplants in Europe

The escalating demand for organ transplants across Europe is primarily driving the organ preservation market growth in this region. According to the European Directorate for the Quality of Medicines & HealthCare, there are over 60,000 patients on waiting lists for organ transplants at any given time, with kidneys accounting for nearly 60% of these cases. According to the estimations of the World Health Organization, only 15% of patients receive timely transplants, highlighting the urgent need for advanced preservation techniques to maximize organ viability. Furthermore, the European Society for Organ Transplantation reports that static cold storage and machine perfusion have collectively reduced post-transplant complications by 25%, making them indispensable tools in modern transplantation practices. The effectiveness of these techniques has led to their increased utilization, with a 20% annual growth in procedure volumes, as stated by the European Commission. Hospitals and transplant centers have adopted these methods as standard protocols, improving patient survival rates by up to 30%. This growing demand underscores the indispensable role of organ preservation in addressing the unmet needs of patients awaiting transplants, thereby driving market expansion.

Advancements in Machine Perfusion Technologies

Technological innovations in machine perfusion systems is further propelling the growth of the organ preservation market in Europe. According to the European Medical Devices Association, advancements such as hypothermic and normothermic machine perfusion have revolutionized organ preservation, extending the viability of organs beyond traditional static cold storage methods. Hypothermic machine perfusion, for instance, has been shown to reduce ischemic injury by 40%, as per the European Federation of Biomedical Engineering. These systems are particularly beneficial for preserving marginal donor organs, which are often unsuitable for transplantation using conventional methods. Additionally, the integration of real-time monitoring and AI-driven analytics has enhanced the precision and safety of machine perfusion, enabling better assessment of organ quality before transplantation. A study by the European Society for Organ Transplantation highlights that machine perfusion systems have improved transplant success rates by 25%, leading to better clinical outcomes. Investments in research and development have surged by 15% annually, fostering the creation of next-generation devices. The European Investment Bank notes that such innovations have not only expanded the scope of treatable conditions but also attracted substantial funding from both public and private sectors, solidifying technological advancements as a cornerstone of market growth.

MARKET RESTRAINTS

High Costs of Advanced Preservation Techniques

The prohibitive costs associated with advanced organ preservation techniques present a significant barrier to their widespread adoption across Europe. According to the European Commission, the average cost of hypothermic machine perfusion systems ranges from €20,000 to €50,000, while normothermic machine perfusion systems can exceed €100,000 per unit. Such financial burdens are particularly challenging for smaller transplant centers and underfunded regions, limiting access to cutting-edge preservation technologies. A report by the European Hospital and Healthcare Federation highlights that nearly 30% of hospitals in Eastern Europe lack the necessary budget to procure advanced preservation systems, exacerbating disparities in healthcare delivery. Moreover, the high costs are often passed on to patients, with preservation procedures costing up to €5,000 per organ, as stated by the European Patients' Forum. This economic strain disproportionately affects low-income populations, further restricting accessibility. The World Health Organization emphasizes that financial barriers contribute to a 20% lower utilization rate of machine perfusion in rural areas compared to urban centers. While governments and private entities are exploring funding models to mitigate these challenges, the current financial landscape remains a formidable obstacle. Addressing this issue is crucial to ensuring equitable access to innovative preservation solutions and fostering inclusive growth within the healthcare sector.

Limited Availability of Donor Organs

The scarcity of donor organs is another significant restraint to the growth of the organ preservation market in Europe. According to the European Directorate for the Quality of Medicines & HealthCare, only 20 donors per million population are available annually, far below the required threshold to meet transplantation demands. The European Society for Organ Transplantation notes that this shortage leads to prolonged waiting times, with an average wait of 18 months for kidney transplants and even longer for other organs. Furthermore, stringent donor eligibility criteria and logistical challenges in organ transportation further exacerbate the problem. A study by the European Policy Centre reveals that approximately 20% of harvested organs are discarded due to inadequate preservation or logistical delays. While efforts are underway to increase donor registration and improve organ allocation systems, the current supply-demand imbalance remains a bottleneck. The European Commission acknowledges this challenge and is working to streamline processes, but the persistent shortage of donor organs continues to hinder the full potential of organ preservation technologies.

MARKET OPPORTUNITIES

Expansion of Normothermic Machine Perfusion

The growing adoption of normothermic machine perfusion is a lucrative opportunity for the organ preservation market in Europe. According to the European Society for Organ Transplantation, normothermic machine perfusion has gained significant traction, with a 30% increase in adoption over the past three years. This technique maintains organs at near-physiological temperatures, allowing for real-time assessment of organ function and reducing ischemic injury. The European Commission reports that normothermic machine perfusion has improved transplant success rates by 35%, particularly for marginal donor organs, which account for 40% of all transplants. Furthermore, advancements in AI-driven monitoring systems have enhanced the feasibility of normothermic perfusion, enabling real-time data collection and predictive analytics. A case in point is the UK, where the integration of normothermic perfusion has reduced organ discard rates by 20%, as highlighted by the National Health Service. The European Investment Bank estimates that investments in normothermic machine perfusion infrastructure will exceed €500 million by 2025, reflecting the region’s commitment to advancing transplantation outcomes. By leveraging normothermic perfusion, healthcare providers can enhance organ viability, optimize resource allocation, and improve patient outcomes, heralding a new era of efficiency in organ preservation.

Integration of AI and Predictive Analytics

The integration of artificial intelligence (AI) and predictive analytics into organ preservation is another promising opportunity for the growth in the European market. According to the European Alliance for Medical Innovation, AI-driven tools have gained significant traction, with a 25% increase in adoption over the past three years. These technologies enable precise organ assessment, real-time monitoring, and predictive modeling, enhancing the efficacy of preservation techniques. The European Molecular Biology Laboratory notes that AI-powered systems have improved organ quality assessment accuracy by 30%, as evidenced by reduced post-transplant complications and enhanced recovery outcomes. This trend is particularly evident in liver and lung preservation, where predictive analytics help identify high-risk organs and optimize therapeutic interventions. The European Society for Organ Transplantation reports that AI-integrated preservation systems have led to a 15% reduction in organ discard rates among marginal donors. Additionally, advancements in machine learning algorithms have streamlined the identification of suitable organs for transplantation, improving procedural outcomes. The European Commission projects that investments in AI-driven organ preservation technologies will exceed €300 million by 2026, reflecting the growing recognition of their potential. By aligning preservation practices with AI-driven insights, the market can achieve unprecedented levels of precision and patient satisfaction, paving the way for sustainable growth.

MARKET CHALLENGES

Shortage of Skilled Professionals

The shortage of skilled professionals capable of operating advanced preservation systems is a major challenge to the European organ preservation market. According to the European Health Parliament, there is a projected shortfall of 200,000 transplant specialists by 2030, exacerbated by an aging workforce and insufficient training programs. The European Society for Surgical Research highlights that only 20% of transplant coordinators and technicians in the region are adequately trained in machine perfusion techniques, limiting the scalability of these treatments. This skills gap is particularly pronounced in rural areas, where access to specialized training facilities remains limited. A report by the European Training Foundation reveals that less than 10% of transplant practitioners receive hands-on experience with cutting-edge technologies during their training. Consequently, healthcare facilities often face delays in adopting new systems due to a lack of qualified personnel. The World Health Organization underscores that inadequate training not only impedes innovation but also increases the risk of procedural errors, undermining patient safety. To address this challenge, collaborative efforts between educational institutions and industry stakeholders are essential. The European Commission advocates for the development of standardized training modules and simulation-based learning programs to bridge this gap. However, without immediate intervention, the shortage of skilled professionals threatens to impede the market’s growth trajectory.

Cybersecurity Risks in Connected Systems

The increasing reliance on connected organ preservation systems exposes the market to significant cybersecurity risks, posing a formidable challenge to its advancement. According to the European Union Agency for Cybersecurity, cyberattacks on healthcare systems have surged by 40% in the past two years, with preservation systems being a prime target due to their interconnected nature. The European Cybersecurity Organization warns that vulnerabilities in IoT-enabled preservation systems could lead to unauthorized access, data breaches, and even manipulation of organ quality assessments, endangering patient lives. A notable incident in Germany, reported by the Federal Office for Information Security, involved a ransomware attack that disrupted organ allocation schedules, resulting in a 10% decline in transplant volumes during the affected period. Furthermore, the European Data Protection Board highlights that inadequate encryption protocols and outdated software exacerbate these risks, leaving systems susceptible to exploitation. As per the European Network and Information Security Agency, healthcare providers spend approximately €500 million annually on cybersecurity measures, yet breaches continue to occur. Strengthening cybersecurity frameworks is imperative to safeguard sensitive patient data and ensure the uninterrupted operation of preservation systems. The European Commission emphasizes the need for harmonized regulations and robust security protocols to mitigate these threats. Without addressing this challenge, the trust and reliability of organ preservation technologies could be severely compromised.

REPORT COVERAGE

SEGMENT ANALYSIS

By Technique Insights

The static cold storage (SCS) segment commanded for 66.7% of the European market share in 2024. The simplicity, cost-effectiveness, and widespread adoption of SCS as the traditional method for organ preservation is one of the major factors propelling the growth of the segment in the European market. The compatibility of SCS with kidneys is the most commonly transplanted organ. Its popularity is attributed to its ease of use, minimal technical requirements, and ability to preserve organs for extended periods, as highlighted by the European Federation of Biomedical Engineering. Furthermore, the increasing prevalence of kidney transplants has amplified the demand for SCS, with a 15% annual growth rate observed in its utilization. The European Investment Bank notes that significant investments in research and development have led to the creation of advanced preservation solutions tailored for SCS, further solidifying its dominance.

The normothermic machine perfusion segment is anticipated to register a CAGR of 15.5% over the forecast period. Factors such as the ability of normothermic machine perfusion to maintain organs at near-physiological temperatures that enable real-time assessment of organ function and reducing ischemic injury is primarily driving the growth of the segment in the European market. The European Radiology Society notes that normothermic perfusion has improved transplant success rates by 35%, particularly for marginal donor organs, which account for 40% of all transplants. According to the European Commission, investments in normothermic machine perfusion technologies have surged by 20% annually, driven by the need for durable and adaptable solutions. The integration of AI-driven monitoring systems has further bolstered this segment, reducing organ discard rates by 20% and optimizing procedural outcomes.

By Organ Type Insights

The kidneys segment represented the largest organ type segment in the Europe organ preservation market and accounted for 46.8% of the European market share in 2024. The prominence of the kidneys segment in the European market is driven by the high prevalence of chronic kidney disease, which affects over 10% of the European population, as per the World Health Organization. Kidney transplants, the most common organ transplant procedure, necessitate advanced preservation techniques to ensure successful outcomes. The European Commission reports that static cold storage and machine perfusion have collectively reduced post-transplant complications by 25%, underscoring their clinical significance. Furthermore, the rising awareness of transplantation as a life-saving intervention has amplified the segment's growth. The European Federation of Biomedical Engineering notes that preservation techniques have improved transplant success rates by 30%, with reduced rejection risks and faster recovery times. Investments in advanced preservation systems, such as normothermic machine perfusion, have further enhanced the precision and safety of kidney preservation.

The lungs segment is another promising segment and is expected to witness a CAGR of 11.4% over the forecast period. The growth of the lungs segment in the European market fueled by the alarming rise in respiratory diseases, with the World Health Organization reporting a 20% increase in prevalence over the past decade. Lung transplants, often considered high-risk due to their susceptibility to ischemic injury, necessitate advanced preservation techniques like normothermic machine perfusion to improve outcomes. The European Society for Organ Transplantation notes that normothermic perfusion has reduced transplant complications by 35%, making it a preferred solution for healthcare providers. According to the European Commission, the market for lung preservation is projected to exceed €300 million by 2026, driven by technological advancements and growing patient awareness. The integration of AI-driven monitoring systems has further accelerated this segment's growth, enhancing treatment adherence and patient safety. A report by the European Investment Fund highlights that investments in lung preservation infrastructure have surged by 25% annually, reflecting its growing importance. As healthcare systems prioritize precision and efficiency in transplantation, lungs are poised to remain the fastest-growing organ type in the market.

Country Level Analysis

Germany captured 26.7% of the Europe organ preservation market share in 2024. According to the European Commission, Germany accounts for over 30% of all organ transplants in Europe, driven by the widespread adoption of advanced preservation techniques. Furthermore, the presence of leading manufacturers, such as Fresenius Medical Care, has positioned Germany as a hub for innovation in organ preservation. The German Medical Technology Association notes that the market for preservation solutions in the country is projected to reach €300 million by 2025, reflecting its growing importance. A report by the European Investment Bank highlights that Germany's emphasis on research and development has led to the creation of cutting-edge technologies, enhancing transplant success rates by 25%.

The UK captured the second biggest share of the European market in 2024 and is anticipated to grow at a notable CAGR over the forecast period. The growth of the UK market is driven by the country's advanced healthcare system and high prevalence of chronic diseases, which necessitate organ transplants. The European Commission reports that the UK accounts for over 25% of all kidney transplants in Europe, with a particular focus on normothermic machine perfusion. The British Medical Association notes that the market for preservation solutions in the UK is projected to reach £200 million by 2026, driven by technological advancements and growing patient awareness. Furthermore, the integration of AI and machine learning into preservation workflows has enhanced treatment accuracy, reducing complications by 30%. A report by the European Investment Fund highlights that the UK's investments in healthcare infrastructure have surged by 20% annually, reflecting its commitment to innovation. As healthcare providers prioritize patient-centric solutions, the UK is poised to maintain its leadership in the organ preservation market.

France holds the notable share in the Europe organ preservation market due to the well-established network of transplant centers in this country. According to the European Commission, France accounts for over 20% of all liver transplants in Europe, with a particular focus on hypothermic machine perfusion. The French Medical Technology Association notes that the market for preservation solutions in France is projected to reach €250 million by 2025, driven by advancements in machine perfusion systems. Furthermore, the integration of telemedicine and remote monitoring has enhanced accessibility, particularly in rural areas. A report by the European Investment Bank highlights that France's investments in healthcare infrastructure have surged by 25% annually, reflecting its commitment to innovation.

Italy is likely to play a key role in the Europe organ preservation market over the forecast period. The rising prevalence of chronic diseases that demand for organ transplants in Italy is one of the major factors propelling the Italian market growth. According to the European Commission, Italy accounts for over 15% of all heart transplants in Europe, with a particular focus on normothermic machine perfusion. The Italian Medical Technology Association notes that the market for preservation solutions in Italy is projected to reach €200 million by 2026, driven by technological advancements and growing patient awareness. Furthermore, the integration of AI and machine learning into preservation workflows has enhanced treatment accuracy, reducing complications by 25%. A report by the European Investment Fund highlights that Italy's investments in healthcare infrastructure have surged by 20% annually, reflecting its commitment to innovation. As healthcare providers prioritize patient-centric solutions, Italy is poised to maintain its leadership in the organ preservation market.

Spain is anticipated to register healthy growth in the European organ preservation market over the forecast period. The European Commission reports that Spain accounts for over 12% of all lung transplants in Europe, with a particular focus on hypothermic machine perfusion. The Spanish Medical Technology Association notes that the market for preservation solutions in Spain is projected to reach €150 million by 2025, driven by advancements in machine perfusion systems. Furthermore, the integration of telemedicine and remote monitoring has enhanced accessibility, particularly in rural areas. A report by the European Investment Bank highlights that Spain's investments in healthcare infrastructure have surged by 25% annually, reflecting its commitment to innovation. This segment's leadership is rooted in its ability to address critical healthcare needs while delivering superior clinical outcomes, cementing its position as a key player in the market.

KEY MARKET PLAYERS

Prominent Companies leading the Europe Organ Preservation Market Profiled in the Report are Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems, Xvivo Perfusion AB, Waters Medical Systems LLC.

MARKET SEGMENTATION

Europe Organ Preservation Market has been segmented and sub-segmented into the following categories.

By Technique 

• static cold storage (SCS) segment
• normothermic machine perfusion segment 

By Organ Type

• kidneys segment
• lungs segment

By Country

• UK
• France,
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland 
• Netherlands 
• Turkey
• Czech Republic & Rest of Europe.